Abstract
Background: Pentacyclic triterpenoids are a biologically active class of phytoconstituents with diverse pharmacological activities, including anti-inflammatory action.
Objective: In the current study, we isolated 3-Acetylmyricadiol, a pentacyclic triterpenoid, from the ethyl acetate bark extract of Myrica esculenta and evaluated it for anti-inflammatory potential.
Methods: The ethyl acetate bark extract of the M. esculenta was subjected to column chromatography to isolate 3-Acetylmyricadiol. MTT assay was performed to check cell viability. The production of proinflammatory mediators like nitric oxide, IL-6, TNF-α were observed after the administration of 5, 10, 20 μM of 3-Acetylmyricadiol in LPS-activated raw 246.7 macrophages by the reported methods.
Results: MTT assay indicated more than 90% cell viability up to 20 μM of 3-Acetylmyricadiol. The administration of 3-Acetylmyricadiol inhibited the production of nitric oxide, IL-6, TNF-α in a dose-dependent manner significantly in comparison to LPS treated cells. The maximum effect was observed at 20 μM of 3-Acetylmyricadiol which resulted in 52.37, 63.10, and 55.37 % inhibition of nitric oxide, IL-6, and TNF-α, respectively.
Conclusion: Our study demonstrated the anti-inflammatory action of 3-Acetylmyricadiol and can serve as a potential candidate in the development of the clinically efficient anti-inflammatory molecule.
Keywords: 3-Acetylmyricadiol, inflammation, nitric oxide, IL-6, TNF-α, raw 264.7 macrophages.
Graphical Abstract
[http://dx.doi.org/10.1016/B978-0-12-809356-6.00022-8]
[http://dx.doi.org/10.1016/j.it.2020.04.006] [PMID: 32362490]
[http://dx.doi.org/10.1016/j.cell.2010.02.029] [PMID: 20303877]
[http://dx.doi.org/10.1177/0192623311428477] [PMID: 22089838]
[http://dx.doi.org/10.14202/vetworld.2018.627-635] [PMID: 29915501]
[http://dx.doi.org/10.1016/B978-0-12-814307-0.00015-3]
[http://dx.doi.org/10.1097/AIA.0b013e318034194e] [PMID: 17426506]
[http://dx.doi.org/10.1189/jlb.0612293] [PMID: 22949334]
[http://dx.doi.org/10.18632/oncotarget.23208] [PMID: 29467962]
[http://dx.doi.org/10.2147/OAEM.S22795] [PMID: 27147851]
[http://dx.doi.org/10.1016/j.bpg.2009.11.005] [PMID: 20227026]
[http://dx.doi.org/10.1007/s11926-007-0020-3] [PMID: 17437665]
[http://dx.doi.org/10.1007/s40264-014-0207-2] [PMID: 25079141]
[http://dx.doi.org/10.1016/j.ejphar.2005.12.052] [PMID: 16436275]
[http://dx.doi.org/10.1055/s-2004-815483] [PMID: 14994184]
[http://dx.doi.org/10.1007/s00011-017-1096-5] [PMID: 28956064]
[http://dx.doi.org/10.3390/plants8060149] [PMID: 31159283]
[http://dx.doi.org/10.3390/toxins2102428] [PMID: 22069560]
[http://dx.doi.org/10.1055/s-2006-957748] [PMID: 9434597]
[http://dx.doi.org/10.21608/ejchem.2019.16055.1975]
[http://dx.doi.org/10.1016/j.biopha.2017.05.063] [PMID: 28549290]
[http://dx.doi.org/10.1016/j.hermed.2017.12.001]
[http://dx.doi.org/10.1016/S1567-5769(01)00086-8] [PMID: 11515807]
[http://dx.doi.org/10.1007/s10787-007-0013-x] [PMID: 18236016]
[http://dx.doi.org/10.1101/cshperspect.a016295] [PMID: 25190079]
[http://dx.doi.org/10.3389/fimmu.2016.00604] [PMID: 28066415]
[http://dx.doi.org/10.1002/path.2287] [PMID: 18161752]
[http://dx.doi.org/10.1007/s00011-013-0633-0] [PMID: 23685857]
[http://dx.doi.org/10.1007/s13199-016-0422-y]
[PMID: 22557437]
[http://dx.doi.org/10.20959/wjpr20174-7734]
[http://dx.doi.org/10.1080/14786419.2011.652959] [PMID: 22260222]
[http://dx.doi.org/10.1016/j.bmc.2008.08.020] [PMID: 18723353]
[http://dx.doi.org/10.1007/s13199-016-0417-8]
[http://dx.doi.org/10.1016/j.jgr.2018.09.004] [PMID: 31695566]
[http://dx.doi.org/10.1016/j.intimp.2018.01.041] [PMID: 29475097]